Meeting Banner
Abstract #1768

Pharmacological Effects of GSK2656157, a Novel PERK Kinase Inhibitor, on Tumor Growth and Angiogenesis Using DCE-MRI in Pancreatic Tumor Model

Hasan Alsaid1, Charity Atkins2, Sarah Lee3, Tinamarie Skedzielewski1, Mary V. Rambo1, Shu-Yun Zhang2, David J. Figueroa2, Brandon Whitcher3, Rakesh Kumar2, Beat M. Jucker1

1Preclinical & Translational Imaging, LAS, PTS, GlaxoSmithKline, King of Prussia, PA, United States; 2Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States; 3Mango Solutions, London, United Kingdom

The eukaryotic initiation factor 2-alpha kinase 3 (EIF2AK3) or PERK is one of three mediators of the unfolded protein response signal transduction pathway. GSK2656157 is the first-in-class, small molecule inhibitor of PERK enzyme activity in cells with an IC50 in the range of 10-30 nM as reflected by inhibition of stress-induced PERK autophosphorylation. In this study, we investigated the pharmacological effect of GSK2656157 on tumor growth and angiogenesis using dynamic contrast enhanced MRI (DCE-MRI) in the BxPc3 xenograft tumor model. The results suggest DCE-MRI can be used as a PD marker to monitor the antiangiogenic effect of a PERK inhibition in human subjects.

Abstract PDF

Keywords

acquisition activation activity addition administration agent alpha analyzed analyzing anesthetized animal anti antigen approved arterial assess axial basis beat blood care cell cells charity class committee concentration continuously contrast converted cover days decreased defined density designed determine determined died discomfort dynamic efficacy enhanced enzyme estimating excluded failure fast female flash frame frames function gadolinium growth human induced inhaled inhibition inhibitor initiation injection input intensities intrinsic investigated king kingdom maintained mango maps marker matrix median mediators mice minimize model molecule monitor monitored mortality mouse much nine novel nude oncology pancreatic pathway perk pharmacological post procedures processing protein quantitative rare recovery reduced reflected regulate repetition resolution respiration response saturation scout session significantly slice solutions specifically spin stress subjects suggest system temperature temporal therapeutic transduction translational treated treatment tumor twelve unfolded vascular vehicle week